SAB Biotherapeutics, Inc.
SABS
$1.79
$0.03992.28%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/22/2025
-
Ticker Report
4/8/2025
-
TipRanks Financial Blog
4/2/2025
-
Simply Wall St
4/1/2025
-
The Fly
3/31/2025
-
SeekingAlpha.com: All News
3/31/2025
-
The Fly
3/31/2025
-
Globe Newswire
2/23/2025
-
Ticker Report
2/14/2025
-
GuruFocus
2/1/2025
-
Ticker Report
1/31/2025
-
Globe Newswire
1/28/2025
-
TipRanks Financial Blog
1/28/2025
-
The Fly
1/28/2025
-
Globe Newswire
1/23/2025
-
Globe Newswire
1/6/2025
-
Insider Monkey
12/23/2024
-
Simply Wall St
11/6/2024
-
Globe Newswire
10/31/2024
-
Globe Newswire
10/19/2024
-
Ticker Report
10/14/2024
-
TipRanks Financial Blog
10/10/2024
-
Ticker Report
10/9/2024
-
The Fly
10/9/2024
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 19 and 23 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
605 679 6980
Address
777 W 41st St.
Miami Beach, FL 33140
Miami Beach, FL 33140
Country
Year Founded
Business Description
Sector
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has...
more